Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Similar fecal immunochemical test results in screening and referral colorectal cancer.

van Turenhout ST, van Rossum LG, Oort FA, Laheij RJ, van Rijn AF, Terhaar sive Droste JS, Fockens P, van der Hulst RW, Bouman AA, Jansen JB, Meijer GA, Dekker E, Mulder CJ.

World J Gastroenterol. 2012 Oct 14;18(38):5397-403. doi: 10.3748/wjg.v18.i38.5397.

PMID:
23082056
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.

Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E.

Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.

PMID:
22108194
[PubMed - indexed for MEDLINE]
3.

Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, Valdez L, Tong L, Ahn C, Kashner M, Argenbright K, Tiro J, Geng Z, Pruitt S, Skinner CS.

JAMA Intern Med. 2013 Oct 14;173(18):1725-32.

PMID:
23921906
[PubMed - indexed for MEDLINE]
4.

Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.

de Wijkerslooth TR, Stoop EM, Bossuyt PM, Meijer GA, van Ballegooijen M, van Roon AH, Stegeman I, Kraaijenhagen RA, Fockens P, van Leerdam ME, Dekker E, Kuipers EJ.

Am J Gastroenterol. 2012 Oct;107(10):1570-8. doi: 10.1038/ajg.2012.249. Epub 2012 Jul 31.

PMID:
22850431
[PubMed - indexed for MEDLINE]
5.

Screening for Colorectal Cancer: An Updated Systematic Review [Internet].

Whitlock EP, Lin J, Liles E, Beil T, Fu R, O'Connor E, Thompson RN, Cardenas T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct.

PMID:
20722162
[PubMed]
Books & Documents
6.

An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.

Kelley L, Swan N, Hughes DJ.

Colorectal Dis. 2013 Sep;15(9):e512-21. doi: 10.1111/codi.12310.

PMID:
23746062
[PubMed - indexed for MEDLINE]
7.

A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.

Levi Z, Birkenfeld S, Vilkin A, Bar-Chana M, Lifshitz I, Chared M, Maoz E, Niv Y.

Int J Cancer. 2011 May 15;128(10):2415-24. doi: 10.1002/ijc.25574.

PMID:
20658527
[PubMed - indexed for MEDLINE]
8.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

PMID:
23074514
[PubMed]
Free PMC Article
9.

Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.

Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM.

Gut. 2014 Mar;63(3):466-71. doi: 10.1136/gutjnl-2013-305013. Epub 2013 Aug 20.

PMID:
23964098
[PubMed - indexed for MEDLINE]
10.

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round.

Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, de Groot K, Stroobants AK, Fockens P, Mundt M, Bossuyt PM, Dekker E.

BMC Gastroenterol. 2012 Jun 19;12:73. doi: 10.1186/1471-230X-12-73.

PMID:
22713100
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.

Cha JM, Lee JI, Joo KR, Shin HP, Park JJ, Jeun JW, Lim JU.

Digestion. 2012;86(4):283-7. doi: 10.1159/000341738. Epub 2012 Oct 9.

PMID:
23051697
[PubMed - indexed for MEDLINE]
12.
13.

Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.

Khalid-de Bakker CA, Jonkers DM, Sanduleanu S, de Bruïne AP, Meijer GA, Janssen JB, van Engeland M, Stockbrügger RW, Masclee AA.

Cancer Prev Res (Phila). 2011 Oct;4(10):1563-71. doi: 10.1158/1940-6207.CAPR-11-0076. Epub 2011 Jul 12.

PMID:
21750209
[PubMed - indexed for MEDLINE]
14.

[Screening for colorectal cancer in Italy, 2010 survey].

Zorzi M, Fedato C, Grazzini G, Sassoli de' Bianchi P, Naldoni C, Pendenza M, Sassatelli R, Senore C, Visioli CB, Zappa M.

Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):55-77. Italian.

PMID:
23293271
[PubMed - indexed for MEDLINE]
15.

Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).

Sali L, Grazzini G, Carozzi F, Castiglione G, Falchini M, Mallardi B, Mantellini P, Ventura L, Regge D, Zappa M, Mascalchi M, Milani S.

Trials. 2013 Mar 15;14:74. doi: 10.1186/1745-6215-14-74.

PMID:
23497601
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.

Raginel T, Puvinel J, Ferrand O, Bouvier V, Levillain R, Ruiz A, Lantieri O, Launoy G, Guittet L.

Gastroenterology. 2013 May;144(5):918-25. doi: 10.1053/j.gastro.2013.01.042. Epub 2013 Feb 1.

PMID:
23376426
[PubMed - indexed for MEDLINE]
17.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J.

J Gastroenterol. 2010 Jul;45(7):703-12. doi: 10.1007/s00535-010-0214-8. Epub 2010 Feb 17.

PMID:
20157748
[PubMed - indexed for MEDLINE]
18.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
[PubMed - indexed for MEDLINE]
19.

Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A; COLONPREV Study Investigators.

N Engl J Med. 2012 Feb 23;366(8):697-706. doi: 10.1056/NEJMoa1108895.

PMID:
22356323
[PubMed - indexed for MEDLINE]
Free Article
20.

Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.

Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, Moretti R, Cremaschini M, Parente EM, Pirola ME.

Endoscopy. 2013;45(1):27-34. doi: 10.1055/s-0032-1325800. Epub 2012 Dec 19.

PMID:
23254404
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk